Corvus Pharmaceuticals, Inc. - COMMON STOCK (CRVS)

CUSIP: 221015100

Q4 2024 13F Holders as of 31 Dec 2024

Holder snapshot 7 signals
Share change
+6,479,160
Put/Call ratio
42%
SEC-reported price per share
$5.35
Number of holders
85
Value change
+$34,704,752
Number of buys
54
Open additional details 1 more signal available
Number of sells
19
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
84,416,811

Security key

221015100

Report period

Q4 2024

Institutions

85

Top holders

10

Ownership snapshot

Top reported holders of CRVS - Corvus Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ADAMS STREET PARTNERS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F 3/4/5 Highest disclosed value: $36,662,493 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

ORBIMED ADVISORS LLC has the largest disclosed position value at $36.66M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ORBIMED ADVISORS LLC's linked filing trail.
Disclosed position value Top 5
ADAMS STREET PARTNERS LLC $17.3M
Terry P. Gould $5.67M
EcoR1 Capital, LLC $64.1K
ORBIMED ADVISORS LLC $36.66M
Point72 Asset Management, L.P. $29.37M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ADAMS STREET PARTNERS LLC
13F 3/4/5
Company · 10%+ Owner
—
mixed-class rows
$17,295,252
3,275,616 shares
— 30 Sep 2024
Terry P. Gould
3/4/5
Director, 10%+ Owner
—
mixed-class rows
$5,670,746
3,290,616 shares
mixed-class rows
— 13 Jun 2024
EcoR1 Capital, LLC
3/4/5
10%+ Owner
—
denominator unverified
$64,051
81,077 shares
— 30 Sep 2021
ORBIMED ADVISORS LLC
13F
Company
13F
—
denominator unverified
$36,662,493
6,943,654 shares
— 30 Sep 2024
Point72 Asset Management, L.P.
13F
Company
13F
—
denominator unverified
$29,371,209
5,562,729 shares
— 30 Sep 2024
SAMLYN CAPITAL, LLC
13F
Company
13F
—
denominator unverified
$23,920,159
4,530,333 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
85
Shares
37,723,156
Rows available
85
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
61
Q4 2024 holders
85
Holder diff
24
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .